Lung Disease News and Research

RSS

New pilot study to monitor lung transplant recipients post-discharge

For many with end-stage lung disease, lung transplantation has become a viable option to extend lives and improve the quality of life.

27 Jul 2020

Malaria drug does not prevent infection of human lung cells with novel coronavirus

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Study shows chloroquine does not prevent SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

A multi-omics single cell analysis on COVID-19

Now, a new study published on the preprint server medRxiv aims to analyze the immune response over time, using multi-omics in the study of a single cell.

21 Jul 2020

Hybrid fungus involved in lung infections discovered

Aspergillus latus, a species of fungus previously found only in soil or plants, has been found for the first time in a hospital environment by an international group of researchers.

19 Jul 2020

Chest X-rays reveal more severe COVID-19 in racial/ethnic minority patients

Racial/ethnic minority patients admitted to the hospital with COVID-19 infection are more likely to have more severe disease on chest X-rays than white/non-Hispanic patients, increasing the likelihood of adverse outcomes, such as intubation or death, according to a study published in the journal Radiology.

16 Jul 2020

Researchers develop new and promising approach for treatment of lung cancer

A new and promising approach for treatment of lung cancer has been developed by researchers at Lund University. The treatment combines a novel surgical approach with smart nanoparticles to specifically target lung tumors. The new study has been published in the July issue of Advanced Therapeutics.

15 Jul 2020

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.

15 Jul 2020

World's first technology aims to help diagnose, treat and manage people with cystic fibrosis

World-first research led by Monash University could hold the key to better monitoring and treatment of lung disease associated with cystic fibrosis (CF) – a condition thousands of people are diagnosed with each year.

15 Jul 2020

Human lungs rejected for transplant can be recovered using cross-circulation with pigs

A new experiment by researchers at the Columbia Engineering and Vanderbilt University may have the solution to this long-standing problem. The team revived and repaired the damaged lungs by cross-circulation support of the whole lungs outside the body using the circulatory system with that of a living pig.

14 Jul 2020

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Now, a new study published on the preprint server medRxiv in July 2020 discusses the explanation in terms of the biological aging markers in patients with severe disease, rather than the chronological age.

13 Jul 2020

Severely injured donor lungs can be successfully recovered outside the body

Respiratory disease is the third leading cause of death worldwide, and lung transplantation is still the only cure for patients with end-stage lung disease.

13 Jul 2020

Patients with high blood sugar at higher risk of COVID-19 complications

The COVID-19 causes severe disease in patients with underlying health conditions, such as diabetes, hypertension, severe lung disease, heart disease, and a weakened immune system.

13 Jul 2020

Experts create new, evidence-based guideline for treatment of NTM lung disease

NTMs are closely related to tuberculosis bacteria and can (but do not need to) cause infectious diseases in humans. They are called "nontuberculous mycobacteria" (NTMs) to distinguish them from tuberculosis bacteria.

13 Jul 2020

Volunteers can now register for coronavirus disease vaccine trials

In an attempt to recruit many volunteers, the National Institute of Allergy and Infectious Diseases (NIAID) has established a new clinical COVID-19 Prevention Trials Network (COVPN) that aims to enroll thousands of volunteers to test various investigational vaccines against the SARS-CoV-2 infection.

10 Jul 2020

Groundbreaking study identifies unique lung cells that may drive pulmonary fibrosis

A groundbreaking study published today and led by the Translational Genomics Research Institute, an affiliate of City of Hope, identifies unique lung cells that may drive Idiopathic Pulmonary Fibrosis, a deadly lung disease that affects hundreds of thousands of Americans, and for which there is no cure.

9 Jul 2020

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical trial to test common asthma inhalers as a treatment for COVID-19 infection.

8 Jul 2020

Asthma inhalers being trialed for treatment of COVID-19

Researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection.

7 Jul 2020

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

7 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020

Lung Disease News and Research

New pilot study to monitor lung transplant recipients post-discharge

Malaria drug does not prevent infection of human lung cells with novel coronavirus

Study shows chloroquine does not prevent SARS-CoV-2

A multi-omics single cell analysis on COVID-19

Hybrid fungus involved in lung infections discovered

Chest X-rays reveal more severe COVID-19 in racial/ethnic minority patients

Researchers develop new and promising approach for treatment of lung cancer

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

World's first technology aims to help diagnose, treat and manage people with cystic fibrosis

Human lungs rejected for transplant can be recovered using cross-circulation with pigs

People with accelerated biological age at increased risk of COVID-19 symptom severity and mortality

Severely injured donor lungs can be successfully recovered outside the body

Patients with high blood sugar at higher risk of COVID-19 complications

Experts create new, evidence-based guideline for treatment of NTM lung disease

Volunteers can now register for coronavirus disease vaccine trials

Groundbreaking study identifies unique lung cells that may drive pulmonary fibrosis

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

Asthma inhalers being trialed for treatment of COVID-19

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Repurposed drug for acute lung injury in COVID-19

The ultimate guide to lung research tools and protocols eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News